Ticker
XOMACompany Name
XOMA ROYALTY CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 72.44M | $ -12.39M | -17.1% |
3/31/2025 | $ 84.63M | $ -5.59M | -6.61% |
12/31/2024 | $ 81.92M | $ -19.29M | -23.55% |
9/30/2024 | $ 84.81M | $ -34.07M | -40.17% |
6/30/2024 | $ 99.99M | $ -22.33M | -22.33% |
3/31/2024 | $ 82.34M | $ -45.09M | -54.75% |
12/31/2023 | $ 88.72M | $ -46.3M | -52.19% |
9/30/2023 | $ 105.96M | $ -32.17M | -30.36% |
6/30/2023 | $ 110.12M | $ -30.84M | -28% |
3/31/2023 | $ 114.53M | $ -30.11M | -26.29% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for XOMA ROYALTY CORP is calculated as follows: Net Inc. Cmn. [ $ -12.71M ] / Equity [ $ 38.04M ]
(=) ROE [ -33.42% ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.25% |
average | 1.51% |
median | 6.45% |
std | 22.68% |